Bought By Many / ManyPets Startup Diligence Report
Proceed only to data-room diligence. The company may be a focused, profitable UK pet-insurance platform with differentiated products and automation upside, but valuation cannot be underwritten without cohort loss ratio, CAC/payback, cash-flow, capacity contracts, legal/regulatory, and cap-table evidence.
Bought By Many / ManyPets Startup Diligence Report
ManyPets is an eligible active private UK insurtech with a verified 2021 unicorn round and a real FY2024/25 profit milestone. The main risk is durability: GWP declined after US/Sweden retreat, cash conversion needs reconciliation, and underwriting capacity, claims automation, cap table, and regulatory contracts remain private.
FY2024/25 was the first annual profit after a £33M loss, so durability, reserves, cash conversion, and normalized EBITDA are unproven publicly.
Diligence request: Obtain audited accounts, QoE, monthly management accounts, cash-flow bridge, reserve triangles, and forecast sensitivities.
Sweden no-renewal and US sale refocus the company but may leave claims, data, employment, customer, indemnity, or regulatory liabilities.
Diligence request: Request Sweden run-off and US sale/transfer documents, reserve schedules, customer notices, and legal opinions.
£20k cover and pre-existing-condition products can attract high-severity claims and adverse selection.
Diligence request: Review product-level loss ratio, pricing rules, exclusions, claim severity, adverse-selection controls, and actuarial memoranda.
Millie handles up to 45% of claims, creating potential upside but also fairness, accuracy, appeal, explainability, and complaint risk.
Diligence request: Review model governance, training data, performance, overrides, QA, decline/partial-payment outcomes, audit logs, and policyholder notices.
Pet insurance economics depend on permissions, distribution conduct, underwriting/capacity contracts, delegated authority, and complaint controls.
Diligence request: Counsel should verify FCA permissions, appointed-representative status if relevant, capacity contracts, claims authority, complaints, and correspondence.
The >$2B 2021 round may include preferences; recent capital filings mean current common-equity value cannot be inferred publicly.
Diligence request: Obtain fully diluted cap table, option pool, debt/warrants, SAFEs if any, round docs, side letters, and liquidation waterfall.
GWP declined 3% due to the US sale; the UK-focused business must now prove efficient growth.
Diligence request: Review continuing-UK GWP bridge, channel-level CAC/payback, renewals, churn, and FY2026 plan.
Differentiated product features are public, but competitors can copy features and market sizing was not independently validated.
Diligence request: Run live quote-shop, win/loss analysis, market-share model, channel benchmark, and independent TAM/SAM validation.
ManyPets has a verified FY2024/25 profitability milestone, but public evidence also shows GWP contraction from strategic retreat and partially verified cash-conversion concerns.
verified confidence: high
FY2024/25 profit, £232M GWP, £62M revenue, and 70% loss ratio are verified from the company release; monthly and segment-level quality of earnings remain private.
| metric | public value | diligence caveat |
|---|---|---|
| Net profit | £6.25M FY2024/25; first annual profit | Reconcile to signed accounts and cash conversion. |
| GWP | £232M, down 3% due to US exit | Separate continuing UK business from exit effects. |
| Loss ratio | 70% | Need cohort triangles and reserving basis. |
Company press metrics are credible but must be matched to audited accounts.
Mixed units require careful rendering; this is a diligence visual, not a financial model.
partially verified confidence: medium
Public financing evidence supports the 2021 unicorn round, but current equity value is not inferable from public filings.
| item | public evidence | diligence request |
|---|---|---|
| Series D | $350M EQT Growth-led round at >$2B valuation | Round docs, preference stack, secondary-sale details. |
| 2025/2026 capital activity | Companies House filing list shows SH01 allotments and resolutions | Explain dilution, option, debt, or restructuring purpose. |
Headline unicorn valuation does not establish current common-equity value.
The UK product suite has clear public differentiators: high lifetime cover limits, pre-existing-condition options, MoneyBack, multi-pet discounts, video vet, and claims automation.
verified confidence: high
ManyPets markets four principal UK plans with cover from £5,000 to £20,000 and meaningful feature add-ons.
| plan or feature | public value | diligence caveat |
|---|---|---|
| Value/Regular/Complete | £5k/£7k/£10k vet-fee cover | Need margin and take-rate by cover tier. |
| Complete Plus | £20k vet-fee cover | High limits can magnify severity and reserve risk. |
| Pre-existing cover | Separate pre-existing-condition product | Need selection controls and claims performance. |
partially verified confidence: medium
Claims and service metrics are central to the product promise and require raw-data validation.
| claim area | public claim | proof needed |
|---|---|---|
| Pre-existing claims paid | 92% in stated period | Claim-level denominator, partials, declines, appeals. |
| Overall claims paid | 97% in stated 2024 window | Raw claims extract and complaints reconciliation. |
| AI claims | Millie handles up to 45% of claims | Audit logs, QA, overrides, false positives/negatives. |
Claims-paid percentages are useful but insufficient without definitions.
Public customer evidence supports meaningful scale and trust, but active policies, renewal cohorts, acquisition channel, claims status, complaints, and LTV are private.
partially verified confidence: medium
The company has public scale claims around half a million pets and visible trust/claims-paid signals.
| signal | public value | limitation |
|---|---|---|
| Scale | More than half a million pets protected / 500k+ pet parents context | Need active policies and pet count by month. |
| Trustpilot | Company page links 4.3 Trustpilot score | Direct review scrape blocked; raw export required. |
| Claims paid | 97% claimed on Many Group page | Need raw claim outcomes and cohort retention. |
partially verified confidence: medium
Underwriting capacity, Joii, Odie, and VetBox are material relationships shaping customer experience and financial outcomes.
| relationship | public signal | diligence focus |
|---|---|---|
| Underwriting capacity | Great Lakes/Munich Re relationship reported | Authority, commission, termination, reserve, and change-of-control terms. |
| Joii video vet | 24/7 vet advice advertised | Clinical governance, data sharing, SLA, and liability. |
| Odie/US transfer | US team transferred to Odie after sale | Customer notices, indemnities, and residual claims. |
Contracts are material to customer experience and economics.
ManyPets has differentiated product and digital-claims evidence, but the 2021 geographic-growth story has been reset by Sweden and US exits.
partially verified confidence: medium
Public evidence supports large-market tailwinds qualitatively, but detailed market sizing was not revalidated and should not be overused.
| topic | evidence | confidence |
|---|---|---|
| Demand tailwind | UKTN referenced pandemic-era dog/cat ownership growth | medium |
| Market report | ResearchAndMarkets UK pet-insurance report page existence | low; title/date only, not full data |
Do not rely on unlicensed report numbers for valuation without independent market work.
verified confidence: medium
Digital claims, pre-existing cover, MoneyBack, and video vet differentiate ManyPets but are contestable.
| theme | public evidence | implication |
|---|---|---|
| Digital claims | UKTN says company was first UK pet insurer to offer online claims | Operational advantage needs current benchmark proof. |
| International expansion | Sweden no new sales/renewals; US division sold | Competitive edge may be UK-specific. |
Competitor positions are deliberately not quantified without independent benchmarking.
ManyPets appears direct-to-consumer led with brand, Trustpilot, feature-led landing pages, and referral/discount messaging; channel mix and CAC are private.
partially verified confidence: medium
Public site pages are optimized around plan comparison, trust, cover levels, video vet, pre-existing cover, and discounts.
| funnel stage | public signal | requested metric |
|---|---|---|
| Awareness | Press office and brand/product pages | Traffic by source, SEO rankings, direct/paid mix. |
| Quote | Plan comparison and cover choices | Quote start-to-bind conversion and pricing competitiveness. |
| Retention | Claims-paid and service promises | Renewal by cohort, claim status, and price change. |
partially verified confidence: medium
Brand visibility is supported by press-office releases and product messaging, but third-party review scraping was blocked and needs raw exports.
| item | status | diligence action |
|---|---|---|
| Trustpilot reputation | 4.3 link visible on company page; direct fetch blocked | Get export and scrape/spot-check reviews legally. |
| PR credibility | Annual-results release hosted by company | Reconcile to audited accounts and media coverage. |
The technology story is credible around digital claims and AI automation, but model governance, IP ownership, security, and vendor dependencies are not public.
partially verified confidence: medium
Millie, online claims, and app/claims workflow are strategic assets if they reduce loss-adjustment expense without conduct failures.
| technology claim | public evidence | diligence test |
|---|---|---|
| AI claims handler Millie | Handles up to 45% of claims | Review model cards, audit logs, QA, overrides, appeals. |
| Online claims heritage | First UK pet insurer with online claims per UKTN | Benchmark current speed, cost, accuracy, and uptime. |
Metrics use different denominators; chart is for diligence focus, not causal proof.
unverified confidence: low
Public sources do not prove proprietary ownership beyond company statements; diligence should verify assignments and licenses.
| area | public status | request |
|---|---|---|
| Proprietary platform | Company claims proprietary technology | Architecture, code ownership, IP assignments, and product roadmap. |
| Security/privacy | Not fully verified in public sources | Pen tests, incident log, DPIAs, DPAs, subprocessors, SOC/ISO evidence if any. |
Absence of public security evidence is not evidence of weakness.
Founders and current CEO/CFO evidence are public, while current organization depth, incentive plan, attrition, and executive transition risk are private.
verified confidence: high
The public narrative ties the company to founders Steven Mendel and Guy Farley and current CEO Luisa Barile / CFO Sue Parris in the FY2024/25 release.
| person | public role or context | follow up |
|---|---|---|
| Steven Mendel | Co-founder per UKTN | Confirm current role, equity, employment/advisory terms. |
| Guy Farley | Co-founder per UKTN | Confirm current role, equity, IP assignment. |
| Luisa Barile / Sue Parris | CEO/CFO quoted in FY2024/25 release | Review contracts, incentives, succession, and board reporting. |
Reporting lines are not publicly verified beyond executive role context.
unverified confidence: low
No public evidence was found for people metrics, ESOP utilization, compensation bands, or employee-relations disputes.
| people topic | public evidence | data room request |
|---|---|---|
| Headcount/attrition | Not found in public research | HRIS export by month, function, geography, voluntary/involuntary attrition. |
| Equity incentives | Share allotments/resolution filings show capital activity | Option pool, grants, exercises, underwater analysis, vesting acceleration. |
HR diligence requires private records.
Legal identity is verified and active, but the most important legal diligence is private: regulated permissions, underwriting/capacity terms, run-off liabilities, contracts, litigation, privacy, and AI conduct.
partially verified confidence: medium
Companies House verifies active private companies and filings; FCA, litigation, IP, and data-protection diligence require counsel.
| entity or matter | public status | diligence action |
|---|---|---|
| MANYPETS LTD | Active private limited company; prior name Bought By Many Ltd | Full statutory registers and subsidiary/branch schedule. |
| MANY GROUP LTD | Active private limited holding company | Group chart, board minutes, shareholder rights, material contracts. |
| FCA/conduct/litigation | Not fully reviewed in this public research | Counsel-led register, complaint, correspondence, and docket review. |
Companies House is necessary but not sufficient for insurance-regulatory diligence.
verified confidence: high
Sweden and US exit evidence is public and material: these events narrow the current platform and require liability review.
| exit area | public evidence | diligence action |
|---|---|---|
| Sweden | No new sales/renewals from 1 July 2023 | Run-off claims, customer notices, regulator correspondence, reserves. |
| United States | US division sold; team transferred to Odie | Sale agreement, indemnities, employment transfer, data migration, warranties. |
Exits may be strategically sensible, but residual liabilities can survive.
| ID | Claim | Status | Sources |
|---|---|---|---|
| EC-001 | MANYPETS LTD is active, private, incorporated 2011-12-19, and formerly named BOUGHT BY MANY LTD. | verified high | SRC-001 |
| EC-002 | MANY GROUP LTD is an active private limited company incorporated 2020-08-12. | verified high | SRC-002 |
| EC-003 | Recent public filings include accounts, confirmation statements, SH01 allotments, and capital resolutions. | verified medium | SRC-002 |
| EC-004 | Bought By Many was founded by Steven Mendel and Guy Farley and launched pet insurance in 2017. | verified high | SRC-003 |
| EC-005 | Bought By Many raised a $350M Series D led by EQT Growth at a valuation above $2B. | verified medium | SRC-003 |
| EC-006 | ManyPets reported FY2024/25 first annual profit of £6.25M, £232M GWP, £62M revenue, 70% loss ratio, and prior-year £33M loss. | verified high | SRC-004 |
| EC-007 | ManyPets stated its goal is to achieve over £10M net profit in FY2025/26. | partially verified medium | SRC-004 |
| EC-008 | ManyPets advertises UK plans with £5k, £7k, £10k, and £20k vet-fee cover and a 4.3 Trustpilot link. | verified high | SRC-006 |
| EC-009 | ManyPets markets a pre-existing-condition product and claims 92% of pre-existing claims were paid over a stated period. | verified medium | SRC-007 |
| EC-010 | ManyPets advertises MoneyBack as a refund feature if no claim is made. | verified high | SRC-011 |
| EC-011 | ManyPets advertises 24/7 online vet advice through Joii. | verified high | SRC-008 |
| EC-012 | ManyPets advertises multi-pet discounts and feature-led plan messaging. | verified high | SRC-006 |
| EC-013 | ManyPets states proprietary technology and its AI claims assistant Millie handles up to 45% of claims. | verified medium | SRC-004 |
| EC-014 | ManyPets stopped offering new sales and renewals in Sweden from 1 July 2023. | verified high | SRC-012 |
| EC-015 | ManyPets sold its US division and transferred the US team to Odie; GWP declined 3% due to the sale. | verified high | SRC-004 |
| EC-016 | ManyPets/Bought By Many had material scale and online-claims differentiation by 2021. | verified medium | SRC-003SRC-010 |
| EC-017 | ManyPets/Many Group publicly states high claims-paid metrics, including 97% overall claims paid for a stated period. | partially verified medium | SRC-009 |
| EC-018 | Third-party market-report pages exist for UK pet-insurance market research, but detailed market sizing was not independently validated in this report. | partially verified low | SRC-017 |
This report is a public-evidence diligence snapshot, not investment advice. Important financial, legal, technical, and contractual facts remain non-public and should be verified directly with management and primary documents before any investment decision.